Hereditary Endocrine Cancer Group

Home | Research & Innovation | Scientific Programmes | Human Cancer Genetics Programme | Hereditary Endocrine Cancer Group

Staff Scientists

  • Alberto Cascón
  • Cristina Rodríguez

Post-Doctoral Fellows

  • Luis Javier Leandro
  • Ángel Mario Martínez
  • Cristina Montero
  • Clara Reglero

Graduate Students

  • Javier de Nicolás
  • Sara Mellid
  • María Monteagudo
  • Carlos Valdivia


  • Alicia Arenas
  • Rocío Letón
  • Gabriela Roberta Radu

Visiting Scientist

  • Alberto Díaz

Our Group is mainly interested in identifying genetic risk factors involved in endocrine tumour susceptibility. Through a comprehensive analysis of tumour genomic features, we have been able to propose diagnostic and prognostic markers, to identify altered pathways that could be therapeutically targeted, and to identify new major susceptibility genes.

We are also interested in defining markers associated with differences in anticancer drug response and toxicity. We are applying targeted and whole-exome next-generation sequencing to a large series of clinically well-characterised patients. The aim is to identify new therapeutic approaches to personalise cancer treatment. These efforts will collectively improve the diagnosis, prognosis, and treatment of patients.